Alexiusdottir, K. K., Möller, P. H., Snaebjornsson, P., Jonasson, L., Olafsdottir, E. J., & Björnsson, E. S. (2012). Association of symptoms of colon cancer patients with tumor location and TNM tumor stage. Scandinavian Journal of Gastroenterology, 47, 795-801.
Chavoshi, S., Haidari Kashl, S., Rezaee Tavirani, M., Ebrahimi, M., Etedali, A., Raessodati, R., et al. (2013). Tumor Markers at a Glance. Journal of Ilam University of Medical Sciences, 21(6), 143-159. (in Persian).
Drauz, K., Gröger, H., & May, O. (2012). Enzyme catalysis in organic synthesis: a comprehensive Handbook, John Wiley & Sons.
Fenocchi, E., Martínez, L., Tolve, J., Montano, D., Rondán, M., Parra-Blanco, A., & Eishi, Y. (2006). Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. European Journal of Cancer Prevention, 15(5), 384-90.
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007). Estimates of the cancer incdence and mortality in Europe in 2006. Annals of Oncology, 18(3), 581-92. doi: 10.1093/annonc/mdl498. Epub 2007 Feb 7. PMID: 17287242.
Gómez-Molina, R., Suárez, M., Martínez, R., Chilet, M., Bauça, J. M., & Mateo, J. (2024). Utility of stool-based tests for colorectal cancer detection: A comprehensive review. Healthcare, 12(16), 1645. https://doi.org/10.3390/healthcare12161645.
Harewood, G. C., & Ahlquist, D. A. (2000). Fecal occult blood testing for iron deficiency: a reappraisal. Digestive Diseases, 18 (2), 75-82.
Javadzade, S.H., Reisi, M., Mostafavi, F., Hasanzade, A., Shahnazi, H., & Sharifirad, G. (2011) Factors associated with the fecal occult blood testing for colorectal cancer screening based on health belief model structures in moderate risk individuals, Isfahan. Journal of Education and Health Promotion, 1, 18. doi: 10.4103/2277-9531.99218. (in Persian).
Inadomi, J.M. (2017). Screening for colorectal neoplasia. The New England Journal of Medicine, 376, 149-156.
Kamiya, S., Hiki, N., Kumagai, K., Honda, M., Nunobe, S., Ohashi, M., Sano, T., & Yamaguchi, T. (2018). Two-point measurement of amylase in drainage fluid predicts severe postoperative pancreatic fistula after gastric cancer surgery. Gastric Cancer, 21(5), 871-878. doi: 10.1007/s10120-018-0805-2.
Kanda, M., Fujiwara, M., Tanaka, C., Kobayashi, D., Iwata, N., Mizuno, A., Yamada, S., Fujii, T., Nakayama, G., Sugimoto, H., Koike, M., & Kodera, Y. (2016). Predictive value of drain amylase content for peripancreatic inflammatory fluid collections after laparoscopic (assisted) distal gastrectomy. Surgical Endoscopy, 30(10), 4353-62. doi: 10.1007/s00464-016-4753-9.
Keyhanian, S., Farhadifar, N., Fotoukian, Z., Pouya, M., & Saravi, M. (2012). Epidemiologic and Malignancy Indices of Gastric Cancer in Patients Referred to Oncology Clinic at Ramsar Emam Sajjad Hospital During 2002-2009. Journal of Shahid Sadoughi University of Medical Sciences, 20(1), 110-118. (in Persian).
Kościelniak-Merak, B., Radosavljević, B., Zając, A., & Tomasik, P. J. (2018). Faecal Occult Blood Point-of-Care Tests. Journal of Gastrointestinal Cancer, 49, 402-405.
Ko, J., Cho, J., & Petrov, M. S. (2020). Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: A systematic review and meta-analysis. Diabetes Research and Clinical Practice, 159, 107974. doi: 10.1016/j.diabres.2019.107974.
Koskenvuo, L., Malila, N., Pitkäniemi, J., Miettinen, J., Heikkinen, S., & Sallinen, V. (2019). Sex differences in faecal occult blood test screening for colorectal cancer. British Journal of Surgery, 106(4), 436-447.
Kumagai, K., Hiki, N., Nunobe, S., Kamiya, S., Tsujiura, M., Ida, S., Ohashi, M., Yamaguchi, T., & Sano, T. (2018). Impact of anatomical position of the pancreas on postoperative complications and drain amylase concentrations after laparoscopic distal gastrectomy for gastric cancer. Surgical Endoscopy, 32(9), 3846-3854. doi: 10.1007/s00464-018-6114-3.
Li, J.N., & Yuan, S.Y. (2019). Fecal occult blood test in colorectal cancer screening. Digestive Diseases, 20(2), 62-64.
Maleki, I., Aminafshari, M. R., Torabizadeh, Z., & Barzin, M. (2012). Severe Lower Gastrointestinal Bleeding, Small Intestine Lymphoma: A Case Report. Govaresh, 17(3), 156-60. (in Persian).
Peng, M., Sun, X., Yuan, X., Tao, C., & Xu, G. (2025). Occult blood in feces is associated with a poor functional outcome of ischemic stroke patients receiving intravenous yhrombolysis. Frontiers in Neurology, 16:1533933. doi: 10.3389/fneur.2025.1533933.
Şahin, T. A., Çelik Güzel, E., & Mete, R. (2022). How Effective is a Fecal Occult Blood Test to Detect Malignancy? Namık Kemal Medical Journal, 10(1), 95-100. DOI: 10.4274/nkmj.galenos.2021.72691.
Schots, J. P., M. Luyer, M.D.P., & Nieuwenhuijzen, G.A.P. (2018). Abdominal Drainage and Amylase Measurement for Detection of Leakage after Gastrectomy for Gastric Cancer. Journal of Gastrointestinal Surgery, 22(7), 1163-1170.
Singal, A. G., Corley, D. A., Kamineni, A., Garcia, M., Zheng, Y., Doria-Rose, P. V., Quinn, V. P., Jensen, C. D., Chubak, J., Tiro, J., Doubeni, C. A., Ghai, N. R., Skinner, C. S., Wernli, K., & Halm, E. A. (2018). Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. The American Journal of Gastroenterology, 113(5), 746-754. doi: 10.1038/s41395-018-0023-x.
Yadollahi Haghighi, N. (2019). A study of the frequency of colonoscopy findings in patients with occult blood in stool at Shahid Sadoughi and Mortaz hospitals in Yazd from 2015 to 2018. A thesis for a general doctor of medicine degree, Faculty of Medicine, Islamic Azad University of Yazd, Yazd, Iran. (in Persian).
)